Injective Rallies 69% in a Month as Annual Revenue Totals $3.58 Million
Photo: TokenPost
Injective (INJ) climbed 68.6% in 30 days to $9.03 on Oct. 16 as U.S. compliance moves and ETF proposals added to its market story, alongside $3.58 million in annual protocol revenue. At 11:49 a.m. ET Friday (15:49 UTC), INJ was trading near $9.03. The increase puts the focus on whether the network's compliance and tokenization activity can develop alongside its market valuation. The revenue figure offers one measure of that gap, but its ratio to valuation depends on which supply figure is used. Injective Institutional Services became a registered transfer agent with the U.S.
Source: TokenPost
